40 related articles for article (PubMed ID: 38453442)
1. Pan-cancer analysis predict that FAT1 is a therapeutic target and immunotherapy biomarker for multiple cancer types including non-small cell lung cancer.
Ding C; Huang H; Wu D; Chen C; Hua Y; Liu J; Li Y; Liu H; Chen J
Front Immunol; 2024; 15():1369073. PubMed ID: 38855103
[TBL] [Abstract][Full Text] [Related]
2. Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer.
Cheng C; Nguyen TT; Tang M; Wang X; Jiang C; Liu Y; Gorlov I; Gorlova O; Iafrate J; Lanuti M; Christiani DC; Amos CI
J Thorac Oncol; 2023 Sep; 18(9):1184-1198. PubMed ID: 37146750
[TBL] [Abstract][Full Text] [Related]
3. The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis.
Zhang G; Dong R; Kong D; Liu B; Zha Y; Luo M
Anticancer Agents Med Chem; 2022; 22(2):223-238. PubMed ID: 34238200
[TBL] [Abstract][Full Text] [Related]
4. [Expression of FAT1 in Lung Adenocarcinoma and Its Relationship
with Immune Cell Infiltration].
Ding C; Zhao W; Huang H; Li Y; Zhang Z; Zhang R; Wang Y; Wu D; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2024 Feb; 27(2):109-117. PubMed ID: 38453442
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer.
Feng Z; Yin Y; Liu B; Zheng Y; Shi D; Zhang H; Qin J
Cancer Control; 2022; 29():10732748221076682. PubMed ID: 35212236
[TBL] [Abstract][Full Text] [Related]
6. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
PeerJ; 2023; 11():e16166. PubMed ID: 37790630
[TBL] [Abstract][Full Text] [Related]
7. Elevated integrin α6 expression is involved in the occurrence and development of lung adenocarcinoma, and predicts a poor prognosis: a study based on immunohistochemical analysis and bioinformatics.
Shen J; Xu J; Chen B; Ma D; Chen Z; Li JC; Zhu C
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1681-1693. PubMed ID: 31175464
[TBL] [Abstract][Full Text] [Related]
8. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
Chen A; Ding S; Shen X; Lin X
Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
[TBL] [Abstract][Full Text] [Related]
9. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
Fan K; Zhang BH; Han D; Sun YC
BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
[TBL] [Abstract][Full Text] [Related]
10. Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations.
Zhang W; Tang Y; Guo Y; Kong Y; Shi F; Sheng C; Wang S; Wang Q
NPJ Precis Oncol; 2022 Jun; 6(1):46. PubMed ID: 35739249
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Atypical Cadherin FAT1 Promotes an Immunosuppressive Tumor Microenvironment
Irshad K; Srivastava C; Malik N; Arora M; Gupta Y; Goswami S; Sarkar C; Suri V; Mahajan S; Gupta DK; Suri A; Chattopadhyay P; Sinha S; Chosdol K
Front Immunol; 2022; 13():813888. PubMed ID: 35720420
[TBL] [Abstract][Full Text] [Related]
12. Fat1 suppresses the tumor-initiating ability of nonsmall cell lung cancer cells by promoting Yes-associated protein 1 nuclear-cytoplasmic translocation.
Li M; Zhong Y; Wang M
Environ Toxicol; 2021 Nov; 36(11):2333-2341. PubMed ID: 34390292
[TBL] [Abstract][Full Text] [Related]
13. Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer.
Zhu G; Ren D; Lei X; Shi R; Zhu S; Zhou N; Zu L; Mello RA; Chen J; Xu S
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808631
[TBL] [Abstract][Full Text] [Related]
14. An annotation-free whole-slide training approach to pathological classification of lung cancer types using deep learning.
Chen CL; Chen CC; Yu WH; Chen SH; Chang YC; Hsu TI; Hsiao M; Yeh CY; Chen CY
Nat Commun; 2021 Feb; 12(1):1193. PubMed ID: 33608558
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]